The University of Chicago Header Logo

CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.

CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients. JCI Insight. 2017 May 04; 2(9).

View in: PubMed